Literature DB >> 20368632

Detection of poliovirus-infected macrophages in thymus of patients with myasthenia gravis.

P Cavalcante1, M Barberis, M Cannone, F Baggi, C Antozzi, L Maggi, F Cornelio, M Barbi, P Didò, S Berrih-Aknin, R Mantegazza, P Bernasconi.   

Abstract

BACKGROUND: Genetic and environmental factors are thought to contribute to the etiology of the autoimmune disease myasthenia gravis (MG). Viral involvement has long been suspected, but direct evidence of involvement has not been found. We recently reported that Toll-like receptor 4 (TLR4)-a key activator of innate immunity-was overexpressed in the thymus of some patients with MG, suggesting that thymic infection by pathogens might be involved in MG pathogenesis. We searched for evidence of intrathymic infection in patients with MG.
METHODS: Twenty-seven MG thymuses (6 involuted, 7 hyperplastic, 5 thymitis, and 9 thymoma) previously tested for TLR4 expression, 18 nonpathologic control thymuses, and 10 pathologic control thymuses from patients without MG (8 thymoma and 2 hyperplastic) were analyzed for cytomegalovirus, varicella-zoster virus, herpes simplex virus types 1 and 2, eubacteria, respiratory syncytial virus, and enteroviruses using PCR techniques. Immunohistochemistry and double immunofluorescence were used to detect enterovirus capsid protein VP1 in thymic specimens and analyze TLR4 expression in VP1-positive cells.
RESULTS: Poliovirus was detected in 4 MG thymuses (14.8%; 2 thymitis and 2 thymoma). No virus was detected in any control thymus. A linear correlation between plus and minus strand poliovirus RNA levels was observed in all 4 thymuses, suggesting persistent thymic infection. VP1 protein was detected in the cytoplasm of CD68-positive macrophages scattered through thymic medulla in all PV-positive thymuses. VP1 and TLR4 colocalized in infected cells.
CONCLUSIONS: Poliovirus-infected macrophages are present in thymus of some patients with myasthenia gravis, suggesting a viral contribution to the intrathymic alterations leading to the disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20368632     DOI: 10.1212/WNL.0b013e3181d7d884

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: enterovirus, thymus and type 1 diabetes pathogenesis.

Authors:  H Jaïdane; F Sané; R Hiar; A Goffard; J Gharbi; V Geenen; D Hober
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

2.  Detection of human polyomavirus 7 in human thymic epithelial tumors.

Authors:  Dorit Rennspiess; Sreedhar Pujari; Marlies Keijzers; Myrurgia A Abdul-Hamid; Monique Hochstenbag; Anne-Marie Dingemans; Anna Kordelia Kurz; Ernst-Jan Speel; Anke Haugg; Diana V Pastrana; Christopher B Buck; Marc H De Baets; Axel Zur Hausen
Journal:  J Thorac Oncol       Date:  2015-02       Impact factor: 15.609

Review 3.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 4.  Tolerance has its limits: how the thymus copes with infection.

Authors:  Cláudio Nunes-Alves; Claudia Nobrega; Samuel M Behar; Margarida Correia-Neves
Journal:  Trends Immunol       Date:  2013-07-16       Impact factor: 16.687

5.  A Systematic Review of the Potential Implication of Infectious Agents in Myasthenia Gravis.

Authors:  Victoria Leopardi; Yu-Mei Chang; Andrew Pham; Jie Luo; Oliver A Garden
Journal:  Front Neurol       Date:  2021-06-14       Impact factor: 4.003

6.  Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis.

Authors:  Paola Cavalcante; Lorenzo Maggi; Lara Colleoni; Rosa Caldara; Teresio Motta; Carmelo Giardina; Carlo Antozzi; Sonia Berrih-Aknin; Pia Bernasconi; Renato Mantegazza
Journal:  Autoimmune Dis       Date:  2011-09-26

7.  Clinical characteristics and therapeutic evaluation of childhood myasthenia gravis.

Authors:  Zhi-Xiao Yang; Kai-Li Xu; Hui Xiong
Journal:  Exp Ther Med       Date:  2015-02-03       Impact factor: 2.447

8.  Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis.

Authors:  Peng Liu; Yiqi Jiang; Shanshan Gu; Yinping Xue; Hongxia Yang; Yongzhao Li; Yaxuan Wang; Congya Yan; Pei Jia; Xiaoting Lin; Guoyan Qi
Journal:  BMC Med       Date:  2021-07-08       Impact factor: 8.775

9.  Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang.

Authors:  Chunmei Wang; Yonghai Lu; Zhixi Chen; Xiaobin Liu; Huangquan Lin; Hui Zhao; Jinyan Chen; Yiuwa Kwan; Saiming Ngai
Journal:  Chin Med       Date:  2012-07-28       Impact factor: 5.455

10.  Clinical Study of Effects of Jian Ji Ning, a Chinese Herbal Medicine Compound Preparation, in Treating Patients with Myasthenia Gravis via the Regulation of Differential MicroRNAs Expression in Serum.

Authors:  Chao Jiang; Ping Liu; Jingsheng Zhang; Wenjing Bao; Shaobo Qiu; Yan Liang; Lin Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2014-01-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.